title: [Treatment of hyperthyroidism (excluding ocular manifestations)].
abstract: Many studies have been performed these last ten years in the way to understand the physiopathology of Graves' Disease. The type of the immune disorder begins to be known with the dosage of the antibodies against T.S.H. receptor and the studies of the T lymphocytes average OKT4/OKT8. Nevertheless treatment is unchanged till now and Thionamide is the anti-thyroid drug generally used alone or together with the beta-blocking agent propranolol. Surgery and radio-iodine-therapy have their special indications.
authors: J
authors: J
authors: Lainée
mesh_terms: D013956:Antithyroid Agents / Q000627:therapeutic use; D006111:Graves Disease / Q000628:therapy*; D006801:Humans; D006980:Hyperthyroidism / Q000601:surgery / Q000628:therapy; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use
chemical_list: D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D011433:Propranolol
vernacular_title: Traitement des hyperthyroïdies (manifestations oculaires exceptées).